Super Micro to Join the Nasdaq 100. Walgreens Gets the Boot.
The change reflects the sharp decline in Walgreens' market value this year and the surge in Super Micro's stock price.
Super Micro Computer Inc. to Join the Nasdaq-100 Index® Beginning July 22, 2024
NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Super Micro Computer Inc. (Nasdaq: SMCI), will become a component of the Nasdaq-100 Index® (Nasdaq: NDX®) and ...
Nano Labs Announces Receipt of Deficiency Letters from Nasdaq
HANGZHOU, China , July 12, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading fabless integrated circuit design company and product solution provider in...
Icon Energy Corp. Announces Listing on Nasdaq and Pricing of $5.0 Million Initial Public Offering
ATHENS, Greece, July 12, 2024 (GLOBE NEWSWIRE) -- Icon Energy Corp . (“Icon Energy” or the “Company”) (Nasdaq: ICON), an international shipping company that provides worldwide seaborne transportati...
China Natural Resources Receives Nasdaq Notification Regarding Minimum Bid Requirements
HONG KONG , July 11, 2024 /PRNewswire/ -- On July 5, 2024, China Natural Resources, Inc. (NASDAQ: CHNR) (the "Company") received a letter from the Listing Qualifications Department of The Nasdaq Ca...
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2024, the Compensation Committee of Crinetics' Board of Directors grante...
MMTEC, Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
HONG KONG , July 10, 2024 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), a China-based technology company that provides access to the U.S. financial markets, tod...
Tevogen Bio's R&D Leadership Discusses The Promise of Its Genetically Unmodified, Off-The-Shelf T Cell Technology For The Treatment of Infectious D...
WARREN, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Dr. Neal Flomenberg and Dr. Lori Grosso of Tevogen Bio Holding Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunothe...
Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”
CAMBRIDGE, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Vyome Therapeutics, a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large m...
Nasdaq and S&P 500 notch record closes as Apple, Amazon, Meta hit record highs
Ryan Detrick, Carson Group chief market strategist, and Nicole Webb, Wealth Enhancement Group SVP, join 'Closing Bell Overtime' to talk the day's record market action.
Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
$10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants $10 million upfront with up to an additional $20 million upon the exe...
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell...
Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
$10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants $10 million upfront with up to an additional $20 million upon the exe...
VS Media Holdings Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Requirement
HONG KONG, July 05, 2024 (GLOBE NEWSWIRE) -- VS Media Holdings Limited (NASDAQ: VSME , the "Company"), a leader in managing a global network of digital creators, today announced the receipt of for...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, July 05, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies f...
Related Companies